ANDOVER, Mass., May 05, 2022 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”), a global provider of technologies that enable advanced processes and improve productivity, today announced it has been recognized as a “3+” company for having three or more female board members by 50/50 Read more
Breakthrough Digital Innovation Provides Wastewater Operators Real-Time Process Recommendations to Optimize Chemical Usage and Aeration STOCKHOLM–(BUSINESS WIRE)–Apr. 7, 2022– Wastewater utilities can now achieve compliance targets while cutting energy consumption from aeration by up to 25% with Xylem Edge Control. This off-the-shelf suite of digital solutions for conventional activated sludge (CAS) plants marks the latest... Read more
CHICAGO – April 4, 2022 – GE Healthcare announced today the FDA pre-market approval (PMA) for its End-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2Anesthesia Delivery System. GE Healthcare is the only manufacturer approved to offer general anesthesia delivery with end-tidal concentration control in the U.S. The company initially released the... Read more
Female scientists are leading ground-breaking research across the world. We at ZEISS strive to #breakthebias by celebrating the fascinating female researchers we have been fortunate to meet in the last year. Learn more about our featured female microscopists who are contributing to advancements across many different fields of science: Dr Kelly Rogers, laboratory head &... Read more
Vabysmo (faricimab-svoa) targets and inhibits two disease pathways that drive neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME) Vabysmo is the only injectable eye medicine approved simultaneously in the US for nAMD and DME, with flexible dosing regimens based on patient need Basel, 31 January 2022 – Roche (SIX: RO, ROG; OTCQX:... Read more